Litvan I, MacIntyre A, Goetz C G, Wenning G K, Jellinger K, Verny M, Bartko J J, Jankovic J, McKee A, Brandel J P, Chaudhuri K R, Lai E C, D'Olhaberriague L, Pearce R K, Agid Y
Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-9130, USA.
Arch Neurol. 1998 Jul;55(7):969-78. doi: 10.1001/archneur.55.7.969.
Whether Parkinson disease (PD) and dementia with Lewy bodies (DLB) represent 2 distinct nosologic entities or are diverse phenotypes of Lewy body disease is subject to debate.
To determine the accuracy of the diagnoses of Lewy body disease, PD, and DLB by validating the clinical diagnoses of 6 neurologists with the neuropathologic findings and to identify early predictors of the diagnoses.
Six raters who were unaware of the neuropathologic diagnoses analyzed 105 clinical vignettes corresponding to 29 cases of Lewy body disease (post hoc analysis of 15 patients with PD and 14 with DLB) and 76 patients without PD or DLB whose cases were confirmed through autopsy findings.
Sensitivity and positive predictive value (PPV) were chosen as validity measures and the K statistic as a reliability measure.
Interrater reliability for the diagnoses of Lewy body disease and PD was moderate for the first visit and substantial for the last, whereas agreement for diagnosis of DLB was fair for the first visit and slight for the last. Median sensitivity for diagnosis of Lewy body disease was 56.9% for the first visit and 67.2% for the last; median PPV was 60.0% and 77.4%, respectively. Median sensitivity for the diagnosis of PD was 73.3% for the first visit and 80.0% for the last; median PPV was 45.9% and 64.1%, respectively. Median sensitivity for the diagnosis of DLB was 17.8% for the first visit and 28.6% for the last; median PPV was 75.0% for the first visit and 55.8% for the last. The raters' results were similar to those of the primary neurologists. Several features differentiated PD from DLB, predicted each disorder, and could be used as clinical pointers.
The low PPV with relatively high sensitivity for the diagnosis of PD suggests overdiagnosis. Conversely, the extremely low sensitivity for the diagnosis of DLB suggests underdiagnosis. Although the case mix included in the study may not reflect the frequency of these disorders in practice, limiting the clinical applicability of the validity measures, the raters' results were similar to those of the primary neurologists who were not exposed to such limitations. Overall, our study confirms features suggested to predict these disorders, except for the early presence of postural imbalance, which is not indicative of either disorder.
帕金森病(PD)和路易体痴呆(DLB)是两种不同的疾病实体,还是路易体病的不同表型,仍存在争议。
通过将6位神经科医生的临床诊断与神经病理学结果进行验证,以确定路易体病、PD和DLB诊断的准确性,并识别诊断的早期预测指标。
6位不知神经病理学诊断结果的评估者分析了105个临床病例,其中包括29例路易体病(对15例PD患者和14例DLB患者的事后分析)以及76例经尸检结果证实无PD或DLB的患者。
选择敏感性和阳性预测值(PPV)作为有效性指标,K统计量作为可靠性指标。
对于路易体病和PD诊断的评估者间可靠性,首次就诊时为中等,末次就诊时为高度;而对于DLB诊断的一致性,首次就诊时为一般,末次就诊时为轻微。路易体病诊断的中位敏感性首次就诊时为56.9%,末次就诊时为67.2%;中位PPV分别为60.0%和77.4%。PD诊断的中位敏感性首次就诊时为73.3%,末次就诊时为80.0%;中位PPV分别为为45.9%和64.1%。DLB诊断的中位敏感性首次就诊时为17.8%,末次就诊时为28.6%;中位PPV首次就诊时为75.0%,末次就诊时为55.8%。评估者的结果与初级神经科医生的结果相似。有几个特征可区分PD与DLB,预测每种疾病,可作为临床指标。
PD诊断的PPV较低而敏感性相对较高,提示存在过度诊断。相反,DLB诊断的敏感性极低,提示存在诊断不足。尽管本研究纳入的病例组合可能无法反映这些疾病在实际中的发病频率,限制了有效性指标的临床适用性,但评估者的结果与未受此类限制的初级神经科医生的结果相似。总体而言,我们的研究证实了所提出的预测这些疾病的特征,但姿势性失衡的早期出现并非这两种疾病的指示性特征除外。